Skip to content
★ Sign in to follow
CJ

Constance J. Hallquist

Board Director
Director
Medifast Inc
Total declarations
21
Company
1
▲ Purchases (3 ops.)
€3,255
▼ Sales (6 ops.)
€1.9M

Latest filing published 30 Oct 2023 for MEDIFAST INC, €393k.

Filing timeline

BuySale
Constance J. Hallquist

Insider track record

Disclosed buys
3
Disclosed sells
6
Signal history

Closed purchases

Market purchases
3
Positive at T+90
33%
Median T+90
-4.3%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 11 May 2023 · 1278 days ago · €1,065
    -71.5%
    Entry US$88.89 · Close at T+365 US$25.35
  • Filed 09 Feb 2023 · 1369 days ago · €1,066
    -47.6%
    Entry US$107.02 · Close at T+365 US$56.13
  • Filed 10 Nov 2022 · 1460 days ago · €1,125
    -45.6%
    Entry US$114.37 · Close at T+365 US$62.17

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Constance J. Hallquist: trading record in brief

This profile gathers the share dealings of Constance J. Hallquist in Medifast Inc, where the filings describe the role as board member. The record holds 21 filings, for trades running from 15 September 2015 to 6 October 2023.

In open-market terms, that means 3 purchases worth €3,255 on one side and 6 sales worth €1.9M on the other. Sales outweigh purchases by €1.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 10 share grants and 2 option exercises. 2023 to date brings 2 purchases and 1 sale.

A typical purchase (the median) is worth €1,066. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 3 purchases with a full 90-day history, the hit rate stands at 33% and the median 90-day move at -4.3%. Past outcomes like these are no guarantee of what comes next.

The latest filing, published on 30 October 2023, reports an open-market sale of €393k in Medifast Inc. The last purchase on record was published on 11 May 2023, which is 1,278 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Constance J. Hallquist

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total

21 of 21 declarations